Evidence map›Paper›PMID 41813332›Full record

ArticleJMIR medical informatics2026

Developing Clinical Decision (Support) Systems Combining the Scientific and Regulatory Perspective: European Insights on Challenges, Requirements, and Practical Guidance.

Sanne E W Vrijlandt, Sanne W C M Janssen, Annemarie M C van Rossum, Niek B Achten, Rianne Oostenbrink

Abstract read
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sanne E W VrijlandtDepartment of Pediatrics, Division of General Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands, 31 (0)10 703 614.ORCID 0009-0008-6765-9818
Sanne W C M JanssenDepartment of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.ORCID 0009-0001-6955-498X
Annemarie M C van RossumDepartment of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-1259-477X
Niek B AchtenDepartment of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-0286-4393
Rianne OostenbrinkDepartment of Pediatrics, Division of General Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands, 31 (0)10 703 614.ORCID 0000-0001-7919-8934

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Clinical decision-making is a critical process where physicians balance risks and benefits. Clinical Decision Support Systems (CDSSs) are increasingly used to help in this process. The regulatory landscape for CDSSs is evolving significantly, with the new European Medical Device Regulation (MDR) now requiring, CE certification for certain CDSSs. This shift poses challenges for health care providers to develop CDSSs in an effective and useful manner while adhering to regulations. This viewpoint comments on diverse challenges and provides solutions to develop a reliable, well integrated and practical tool for clinical use. Using three tools (the Early Onset Sepsis Calculator, Feverkidstool, and Neonatal Procalcitonin Intervention Study algorithm) as examples, we explore the development of CDSSs across four core characteristics: scientific basis, technical aspects, safety, and sustainability. These characteristics recur across the main development processes; scientific development, regulatory assessment, and implementation in routine practice. Successful integration of CDSSs into clinical practice requires a comprehensive understanding of the interconnections between these processes. For example, decisions on algorithm validation and platform selection in the scientific process influence choices for technical safety during the regulatory process. Developers should consider both regulation requirements and clinical needs, to create CDSSs that are not only compliant but also adaptable to the rapidly changing healthcare landscape. We outline a developer's checklist, for practical guidance, but also appeal for structural support, including national protocols and dedicated hospital roles, to help developers implement CDSSs successfully.

Indexed as

Decision Support Systems, ClinicalEuropeHumansclinical decision support systemsdiagnostic reasoninginfection diseasespediatricsregulatory requirements

Identifiers

PMID41813332
PMCPMC12978881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.